Optimum management of Citrobacter koseri infection

Deveci A., Coban A. Y.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, cilt.12, sa.9, ss.1137-1142, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 12 Sayı: 9
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1586/14787210.2014.944505
  • Dergi Adı: EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1137-1142
  • Anahtar Kelimeler: Citrobacter koseri, infection, management, treatment, ANTIMICROBIAL SURVEILLANCE PROGRAM, SPECTRUM BETA-LACTAMASES, BRAIN-ABSCESS, CEPHALOSPORINS, TIGECYCLINE, MENINGITIS, BACTEREMIA, RESISTANCE
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Low virulent Citrobacter koseri can cause life threatening infections. Neonates and other immunocompromised patients are particularly susceptible to infection from C. koseri. Any infection due to C. koseri mandates antimicrobial therapy based on the sensitivity of the pathogen microorganism. Various types of antibiotics, including aminoglycosides carbapenems, cephalosporins, chloramphenicol and quinolones, are used for the treatment of C. koseri infections. The rational choice of antimicrobial therapy for Citrobacter infections is a challenge for clinicians because there is a sustained increase in antibacterial resistance. We reviewed antimicrobial agents used for C. koseri infections in this review.